Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone in adolescents with schizophrenia
NCT00257192Phase 3Terminated
- Sponsor
- Viatris
- Start
- Apr 2006
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of ziprasidone in schizophrenia, sponsored by Viatris. Started Apr 2006; status: terminated.
02
Drugs
ziprasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00257192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257192.